ICON Announces Pricing of USD 2 Billion Notes
DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading healthcare intelligence and clinical research organization, today announced... Read more.
HRT Investors With Large Losses Should Contact Robbins LLP for Information About Their Rights in Connection With the HireRight Holdings Corp. Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$HRT #HRT–Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf... Read more.
Link Logistics Provides First Quarter 2024 Update
Signed 17.8 million square feet of leasing Executed $6.5 billion of refinancings over five transactions NEW YORK–(BUSINESS WIRE)–Link Logistics (“Link”... Read more.
FGIC Announces Opportunity to Join Transaction Support Agreement and Become Eligible to Receive Early Joinder Fee
NEW YORK–(BUSINESS WIRE)–Financial Guaranty Insurance Company (“FGIC”) announced it has launched a process for beneficial owners of certain FGIC-insured... Read more.
Cementos Pacasmayo S.A.A. Has Filed Its Annual Report for the Fiscal Year Ended December 31, 2023
LIMA, Peru–(BUSINESS WIRE)–Cementos Pacasmayo S.A.A. and subsidiaries (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Pacasmayo”) a leading cement... Read more.
DigitalBridge Reports First Quarter 2024 Financial Results
BOCA RATON, Fla.–(BUSINESS WIRE)–#digitalbridge—DigitalBridge Group, Inc. (“DigitalBridge” or the “Company”) (NYSE: DBRG), a leading global... Read more.
DigitalBridge Reports First Quarter 2024 Financial Results
BOCA RATON, Fla.–(BUSINESS WIRE)–#digitalbridge—DigitalBridge Group, Inc. (“DigitalBridge” or the “Company”) (NYSE: DBRG), a leading global... Read more.
Lemonade Announces First Quarter 2024 Financial Results
NEW YORK–(BUSINESS WIRE)–Lemonade, Inc. (NYSE: LMND) has released its first quarter 2024 financial results by posting them to its website. Please view... Read more.
Lemonade Announces First Quarter 2024 Financial Results
NEW YORK–(BUSINESS WIRE)–Lemonade, Inc. (NYSE: LMND) has released its first quarter 2024 financial results by posting them to its website. Please view... Read more.
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
$25 million funded at close; up to $25 million of additional capital available at the Company’s option, based on the achievement of certain revenue thresholds... Read more.